Allergy, Asthma & Immunology Education and Research Organization, Inc. (ARTrustTM)
• Reached corpus goal of $10 million.
2011 - 2012
• The ARTrust carried out active fundraising.
• As a presidential initiative of Dennis K. Ledford, MD, FAAAAI, a goal was set for the corpus to reach $10 million.
• The ART will now be known as the ARTrust.
• The AAAAI Board of Directors approves the proposal to set-up the ARTrust as a separate 501(c)(3) corporation organized and operated to act as a supporting organization to the AAAAI.
2007 - 2008
• Under Dr. Lou Mendelson's leadership, the ART leadership determines various target groups within the AAAAI membership and develops specific marketing messages for each target audience.
2006 - 2007
• Formerly the Education and Research Trust (ERT), the new Allergy, Asthma and Immunology Education and Research Trust (ART) is created to offer expanded giving options, including designated giving and the creation of endowments. The ART's expanded giving options allow the AAAAI to enhance efforts that support A/I training programs, support practicing A/Is and the patients they care for, increase educational opportunities for members and foster research.
• The mission of the Allergy, Asthma and Immunology Education and Research Trust is to find treatments and cures for the millions of people suffering from allergies, asthma and other immunologic diseases by supporting education and research.
2005 - 2006
• A Hurricane Katrina Fund was established by the AAAAI Board of Directors and through donations of AAAAI members to aid the allergy/immunology programs deeply impacted by the hurricane.
• ERT assists two Allergy/Immunology training programs deeply affected by Hurricane Katrina by awarding a Hurricane Katrina Program Assistance Grant to Tulane University and LSU-New Orleans, and ERT Hurricane Katrina FIT Travel Scholarships to ten FITs from Tulane University and LSU-New Orleans to assist them in attending the 2006 AAAAI Annual Meeting in Miami Beach.
• ERT establishes Growth Funds.
• ERT offers several new and more diverse grants to various membership groups within the AAAAI. Including: clinical research grants, allied health travel grants, and support of the Phoenix Program Award as one of the founding partners.
• ERT surpasses $2 million in awards granted since the ERT's inception in 1991.
• ERT governing bodies restructured to include the Oversight Committee (overseas all ERT activities), the Resource Development Committee (principal fund raising entity) and the ERT Board of Trustees (award granting body.)
• Building upon the past success of the "Looking to Our Future" fund raising campaign, the ERT Development Committee initiated a new development effort that seeks to grow the ERT and build personal relationships within the allergy/immunology specialty.
• "Securing Our Future" effort begins offering many giving opportunities to assist the ERT Development Committee's goal of increasing the ERT corpus.
• The successful completion of the "Looking to Our Future" campaign was announced at the 56th AAAAI Business Meeting in San Diego. The value of paid and pledged commitments to the ERT is $8,300,000 as of June 1, 2000.
• To successfully continue the ERT campaign, the 4,500 members of the AAAAI were challenged to pledge $5 million to complete the goal of a $10 million trust.
• The ERT awards its first grant: "Faculty Development Award."
• John Anderson, MD, FAAAAI, in his presidential address, refocused the attention of the AAAAI members on the importance of supporting education and research in our academic centers of allergy and immunology.
• The education and research fund was reorganized into a trust called the Education and Research Trust - ERT.
• A $10 million campaign was announced to boost the impact of the ERT upon the specialty, to involve both the AAAAI membership and the pharmaceutical industry to fund the ERT.
• An education and research fund was established as part of the American Academy of Allergy, Asthma & Immunology, founded under the leadership of Jordan N. Fink, MD, FAAAAI and Phillip L. Lieberman, MD, FAAAAI.